메뉴 건너뛰기




Volumn 60, Issue 2, 2012, Pages 99-106

Antibodies in the treatment of aplastic anemia

Author keywords

Alemtuzumab; Antibodies; Antithymocyte globulin; Aplastic anemia

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; DOMESTIC; IMMUNOGLOBULIN G1; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; RITUXIMAB; THYMOCYTE ANTIBODY; THYROGLOBULIN; UNCLASSIFIED DRUG;

EID: 84858707747     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0164-3     Document Type: Review
Times cited : (13)

References (62)
  • 1
    • 77955659229 scopus 로고    scopus 로고
    • Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: A single center retrospective study
    • Atta EH, Dias DS, Marra VL et al (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single center retrospective study. Ann Hematol 89:851-859
    • (2010) Ann Hematol , vol.89 , pp. 851-859
    • Atta, E.H.1    Dias, D.S.2    Marra, V.L.3
  • 2
    • 0028913625 scopus 로고
    • Antilymphocyte globulin, cyclosporin and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party
    • Bacigalupo A, Broccia G, Corda G et al (1995) Antilymphocyte globulin, cyclosporin and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85:1348-1353
    • (1995) Blood , vol.85 , pp. 1348-1353
    • Bacigalupo, A.1    Broccia, G.2    Corda, G.3
  • 3
    • 78449251007 scopus 로고    scopus 로고
    • The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine A to treat patients with acquired severe aplastic anemia
    • Bing H, Siyi Y, Weg Z et al (2010) The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine A to treat patients with acquired severe aplastic anemia. Acta Haematol 124:245-250
    • (2010) Acta Haematol , vol.124 , pp. 245-250
    • Bing, H.1    Siyi, Y.2    Weg, Z.3
  • 4
    • 33750473058 scopus 로고    scopus 로고
    • Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia [12]
    • DOI 10.1080/10428190600709630, PII R12Q0078222L787N
    • Castiglione MG, Scatena P, Pandolfo C et al (2006) Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia. Leuk Lymphoma 47:1985-1986 (Pubitemid 44649793)
    • (2006) Leukemia and Lymphoma , vol.47 , Issue.9 , pp. 1985-1986
    • Castiglioni, M.G.1    Scatena, P.2    Pandolfo, C.3    Mechelli, S.4    Bianchi, M.5
  • 5
    • 0020679706 scopus 로고
    • Antithymocyte globulin treatment in patients with aplastic anemia. A prospective randomized trial
    • Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308:113-118 (Pubitemid 13224115)
    • (1983) New England Journal of Medicine , vol.308 , Issue.3 , pp. 113-118
    • Champlin, R.1    Ho, W.2    Gale, R.P.3
  • 8
    • 73149090804 scopus 로고    scopus 로고
    • Changes in cytokine profile pre and post immunosuppression in acquired aplastic anemia
    • Dufour C, Ferretti E, Bagnasco F et al (2009) Changes in cytokine profile pre and post immunosuppression in acquired aplastic anemia. Haematologica 94:1743-1747
    • (2009) Haematologica , vol.94 , pp. 1743-1747
    • Dufour, C.1    Ferretti, E.2    Bagnasco, F.3
  • 9
    • 0025865140 scopus 로고
    • Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine
    • The German Aplastic Anemia Study Group
    • Frickhofen N, Kaltwasser JP, Schrezenmeier H et al (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 324:1297-1304
    • (1991) N Engl J Med , vol.324 , pp. 1297-1304
    • Frickhofen, N.1    Kaltwasser, J.P.2    Schrezenmeier, H.3
  • 10
    • 0037441586 scopus 로고    scopus 로고
    • Antithymocyte globulin with or without cyclosporin A: 11-Year follow-up of a randomized trial comparing treatments of aplastic anemia
    • DOI 10.1182/blood-2002-04-1134
    • Frickhofen N, Heimpel H, Kaltwasser JP et al (2003) Antithymocyte globulin with or without cyclosporine A: 11-year follow-up of a randomised trial comparing treatments of aplastic anemia. Blood 101:1236-1242 (Pubitemid 36182490)
    • (2003) Blood , vol.101 , Issue.4 , pp. 1236-1242
    • Frickhofen, N.1    Heimpel, H.2    Kaltwasser, J.P.3    Schrezenmeier, H.4
  • 11
    • 73449106771 scopus 로고    scopus 로고
    • Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
    • Fuijiwara S, Miyake H, Nosaka K (2009) Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia. Int J Hematol 90:471-475
    • (2009) Int J Hematol , vol.90 , pp. 471-475
    • Fuijiwara, S.1    Miyake, H.2    Nosaka, K.3
  • 12
    • 33644505809 scopus 로고    scopus 로고
    • Allografting in patients with severe aplastic anemia using peripheral blood stem cells and a fludarabine-based conditoning regimen: The Mexican Experience
    • Gómez-Almaguer D, Vela-Ojeda J, Jaime-Pérez JC et al (2006) Allografting in patients with severe aplastic anemia using peripheral blood stem cells and a fludarabine-based conditoning regimen: the Mexican Experience. Am J Hematol 81:157-161
    • (2006) Am J Hematol , vol.81 , pp. 157-161
    • Gómez-Almaguer, D.1    Vela-Ojeda, J.2    Jaime-Pérez, J.C.3
  • 14
    • 77949321839 scopus 로고    scopus 로고
    • Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia
    • Gómez-Almaguer D, Jaime-Perez JC, Garza-Rodriguez V et al (2010a) Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia. Ann Hematol 89:299-303
    • (2010) Ann Hematol , vol.89 , pp. 299-303
    • Gómez-Almaguer, D.1    Jaime-Perez, J.C.2    Garza-Rodriguez, V.3
  • 15
    • 78649690155 scopus 로고    scopus 로고
    • Low dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoinmune cytopenias
    • Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L et al (2010b) Low dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoinmune cytopenias. Blood 116:4783-4785
    • (2010) Blood , vol.116 , pp. 4783-4785
    • Gómez-Almaguer, D.1    Solano-Genesta, M.2    Tarín-Arzaga, L.3
  • 16
    • 15544377256 scopus 로고    scopus 로고
    • Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning
    • DOI 10.1038/sj.bmt.1704799
    • Grupta V, Ball SE, Sage D et al (2005) Marrow transplants from matched unrelated donors for aplastic anemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 35:467-471 (Pubitemid 40403349)
    • (2005) Bone Marrow Transplantation , vol.35 , Issue.5 , pp. 467-471
    • Gupta, V.1    Ball, S.E.2    Sage, D.3    Ortin, M.4    Freires, M.5    Gordon-Smith, E.C.6    Marsh, J.C.W.7
  • 17
    • 28544432438 scopus 로고    scopus 로고
    • Aplastic anemia successfully treated with rituximab
    • DOI 10.1002/ajh.20428
    • Hansen PB, Lauritzen AM (2005) Aplastic anemia successfully treated with rituximab. Am J Hematol 80:292-294 (Pubitemid 41746177)
    • (2005) American Journal of Hematology , vol.80 , Issue.4 , pp. 292-294
    • Hansen, P.B.1    Lauritzen, A.M.F.2
  • 20
    • 79958021197 scopus 로고    scopus 로고
    • Relapse of aplastic anemia in children after immunossuppresive therapy: A report from the Japan Childhood Aplastic Anemia Study Group
    • Kamio T, Ito E, Ohara A et al (2011) Relapse of aplastic anemia in children after immunossuppresive therapy: a report from the Japan Childhood Aplastic Anemia Study Group. Haematologica 96:814-819
    • (2011) Haematologica , vol.96 , pp. 814-819
    • Kamio, T.1    Ito, E.2    Ohara, A.3
  • 21
    • 56949093138 scopus 로고    scopus 로고
    • A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
    • Kim H, Min YJ, Baeck JH et al (2009) A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome. Leuk Res 33:222-231
    • (2009) Leuk Res , vol.33 , pp. 222-231
    • Kim, H.1    Min, Y.J.2    Baeck, J.H.3
  • 22
    • 80955177543 scopus 로고    scopus 로고
    • The Third Consensus Conference on the treatment of aplastic anemia
    • Kojima S, Nakao S, Young N et al (2011) The Third Consensus Conference on the treatment of aplastic anemia. Int J Hematol 93:832-837
    • (2011) Int J Hematol , vol.93 , pp. 832-837
    • Kojima, S.1    Nakao, S.2    Young, N.3
  • 23
    • 0034668824 scopus 로고    scopus 로고
    • A critical role for B cells in the development of memory CD4 cells
    • Linton PJ, Harbertson J, Bradley LM (2000) A critical role for B cells in the development of memory CD4 cells. J Immunol 165:5558-5565
    • (2000) J Immunol , vol.165 , pp. 5558-5565
    • Linton, P.J.1    Harbertson, J.2    Bradley, L.M.3
  • 25
    • 0029048258 scopus 로고
    • Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia
    • Maciejewski JP, Selleri C, Sato T et al (1995) Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 91:245-252
    • (1995) Br J Haematol , vol.91 , pp. 245-252
    • Maciejewski, J.P.1    Selleri, C.2    Sato, T.3
  • 26
    • 0242579305 scopus 로고    scopus 로고
    • Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia
    • DOI 10.1182/blood-2003-04-1032
    • Maciejewski JP, Sloand EM, Nuñez O et al (2003) Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood 102:3584-3586 (Pubitemid 37409374)
    • (2003) Blood , vol.102 , Issue.10 , pp. 3584-3586
    • Maciejewski, J.P.1    Sloand, E.M.2    Nunez, O.3    Boss, C.4    Young, N.S.5
  • 28
    • 0036381344 scopus 로고    scopus 로고
    • Seeing the good and bad in aplastic anemia: Is autoimmunity in AA dysregulated or antineoplastic?
    • Nissen C, Schubert J (2002) Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or antineoplastic? Hematol J 3:169-175
    • (2002) Hematol J , vol.3 , pp. 169-175
    • Nissen, C.1    Schubert, J.2
  • 29
    • 62949229281 scopus 로고    scopus 로고
    • Immunosuppressive treatment for aplastic anemia: Are we hitting the ceiling?
    • Passweg J, Tichelli A (2009) Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica 94: 310-312
    • (2009) Haematologica , vol.94 , pp. 310-312
    • Passweg, J.1    Tichelli, A.2
  • 30
    • 78549294158 scopus 로고    scopus 로고
    • Autoantibodies specific to hnRNP K: A new diagnostic marker for immune pathophysiology in aplastic anemia
    • Qi Z, Takamatsu H, Espinoza JL et al (2010) Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia. Ann Hematol 89:1255-1263
    • (2010) Ann Hematol , vol.89 , pp. 1255-1263
    • Qi, Z.1    Takamatsu, H.2    Espinoza, J.L.3
  • 31
    • 78650316570 scopus 로고    scopus 로고
    • Immunosuppresive therapies in the management of immune-mediated marrow failures in adults: Where we stand and where we are going
    • Risitano AM (2011) Immunosuppresive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going. Br J Haematol 152:127-140
    • (2011) Br J Haematol , vol.152 , pp. 127-140
    • Risitano, A.M.1
  • 32
    • 3242782610 scopus 로고    scopus 로고
    • In-vivo dominant immune responses in aplastic anaemia: Molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing
    • DOI 10.1016/S0140-6736(04)16724-X, PII S014067360416724X
    • Risitano AM, Maciejewski J, Green S et al (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364:355-364 (Pubitemid 38970012)
    • (2004) Lancet , vol.364 , Issue.9431 , pp. 355-364
    • Risitano, A.M.1    Maciejewski, J.P.2    Green, S.3    Plasilova, M.4    Zeng, W.5    Young, N.S.6
  • 33
    • 76449093834 scopus 로고    scopus 로고
    • Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anemia and single-lineage bone marrow failure: A pilot study and a survey from the EBMT WPSSAA
    • Risitano AM, Selleri C, Serio B et al (2010) Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anemia and single-lineage bone marrow failure: a pilot study and a survey from the EBMT WPSSAA. Br J Haematol 148:791-796
    • (2010) Br J Haematol , vol.148 , pp. 791-796
    • Risitano, A.M.1    Selleri, C.2    Serio, B.3
  • 34
    • 0037420270 scopus 로고    scopus 로고
    • Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia: Association between Hematologic Response and Long-term Outcome
    • DOI 10.1001/jama.289.9.1130
    • Rosenfeld S, Follmann D, Nunez O et al (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematopoietic response and long term outcome. JAMA 289:1130-1135 (Pubitemid 37430327)
    • (2003) Journal of the American Medical Association , vol.289 , Issue.9 , pp. 1130-1135
    • Rosenfeld, S.1    Follmann, D.2    Nunez, O.3    Young, N.S.4
  • 35
    • 84858699080 scopus 로고    scopus 로고
    • Hipoplasias y displasias medulares
    • Ruiz-Argüelles GJ (ed) 4th edn. Editorial Médica Panamericana, México
    • Ruiz-Argüelles GJ (2009) Hipoplasias y displasias medulares. In: Ruiz-Argüelles GJ (ed) Fundamentos de Hematología, 4th edn. Editorial Médica Panamericana, México, pp 117-127
    • (2009) Fundamentos de Hematología , pp. 117-127
    • Ruiz-Argüelles, G.J.1
  • 37
    • 66349094784 scopus 로고    scopus 로고
    • Making allogeneic bone marrow transplantation available to patients in developing countries: The Mexican Experience
    • Ruiz-Argüelles GJ, Gómez-Almaguer D (2008) Making allogeneic bone marrow transplantation available to patients in developing countries: the Mexican Experience. Open Hematol J 2:30-36
    • (2008) Open Hematol J , vol.2 , pp. 30-36
    • Ruiz-Argüelles, G.J.1    Gómez-Almaguer, D.2
  • 38
    • 0345168165 scopus 로고    scopus 로고
    • Long term results of the immunosuppressive treatment of patients with severe, acquired aplastic anemia: A single institution study
    • Ruiz-Argüelles GJ, Gómez-Rangel D (2003) Long term results of the immunosuppressive treatment of patients with severe, acquired aplastic anemia: a single institution study. Acta Haematol 110:184-187
    • (2003) Acta Haematol , vol.110 , pp. 184-187
    • Ruiz-Argüelles, G.J.1    Gómez-Rangel, D.2
  • 40
    • 0022755650 scopus 로고
    • Preparation and characteristics of an equine anti-human thymocyte gamma globulin produced in Mexico
    • in Spanish
    • Ruiz-Argüelles A, Salvador Ruiz-González JD, Miguel Presno-Bernal J (1986) Preparation and characteristics of an equine anti-human thymocyte gamma globulin produced in Mexico (in Spanish). Rev Invest Clin 38:273-278
    • (1986) Rev Invest Clin , vol.38 , pp. 273-278
    • Ruiz-Argüelles, A.1    Salvador Ruiz-González, J.D.2    Miguel Presno-Bernal, J.3
  • 42
    • 33646688643 scopus 로고    scopus 로고
    • Treatment of severe aplastic anaemia with combined immunosuppression: Anti-thymocyte globulin, ciclosporin and mycophenolate mofetil
    • DOI 10.1111/j.1365-2141.2006.06085.x
    • Scheinberg P, Nuñez O, Wu C et al (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anthytimocyte globulin, cyclosporine and mycophenolate mofetil. Br J Haematol 133:606-611 (Pubitemid 43742774)
    • (2006) British Journal of Haematology , vol.133 , Issue.6 , pp. 606-611
    • Scheinberg, P.1    Nunez, O.2    Wu, C.3    Young, N.S.4
  • 43
    • 62949210719 scopus 로고    scopus 로고
    • Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with and without sirolimus, a prospective randomized study
    • Scheinberg P, Wu CO, Nuñez O et al (2009a) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with and without sirolimus, a prospective randomized study. Haematologica 94:348-354
    • (2009) Haematologica , vol.94 , pp. 348-354
    • Scheinberg, P.1    Wu, C.O.2    Nuñez, O.3
  • 44
    • 58149090759 scopus 로고    scopus 로고
    • Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
    • Scheinberg P, Wu CO, Nuñez O et al (2009b) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144:206-216
    • (2009) Br J Haematol , vol.144 , pp. 206-216
    • Scheinberg, P.1    Wu, C.O.2    Nuñez, O.3
  • 45
    • 79959479873 scopus 로고    scopus 로고
    • A randomized trial of horse versus rabbit antithymocyte globulin in severe acquired aplastic anemia
    • Scheinberg P, Wu CO, Scheinberg P et al (2010a) A randomized trial of horse versus rabbit antithymocyte globulin in severe acquired aplastic anemia. Blood 116:a4
    • (2010) Blood , vol.116
    • Scheinberg, P.1    Wu, C.O.2    Scheinberg, P.3
  • 46
    • 79961102745 scopus 로고    scopus 로고
    • Alemtuzumab (Campath)monotherapy for severe aplastic anemia
    • Scheinberg P, Wu CO, Scheinberg P et al (2010b) Alemtuzumab (Campath)monotherapy for severe aplastic anemia. Blood 116:a1167
    • (2010) Blood , vol.116
    • Scheinberg, P.1    Wu, C.O.2    Scheinberg, P.3
  • 47
    • 79959418648 scopus 로고    scopus 로고
    • Novel immunosuppressive strategies for bone marrow failure syndromes: A focus on Alemtuzumab
    • Selleri C, Serio B, Risitano AM (2011) Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on Alemtuzumab. Mini Rev Med Chem 11:536-543
    • (2011) Mini Rev Med Chem , vol.11 , pp. 536-543
    • Selleri, C.1    Serio, B.2    Risitano, A.M.3
  • 48
    • 79958063092 scopus 로고    scopus 로고
    • Costs and consequences of immunosuppressive therapy in children with aplastic anemia
    • Shereck EB, Deyell RJ, Kurre P (2011) Costs and consequences of immunosuppressive therapy in children with aplastic anemia. Haematologica 96:793-795
    • (2011) Haematologica , vol.96 , pp. 793-795
    • Shereck, E.B.1    Deyell, R.J.2    Kurre, P.3
  • 49
    • 0035525528 scopus 로고    scopus 로고
    • From T to B and back again: Positive feedback in systemic autoimmune disease
    • Shlomchik MJ, Craft JE, Mamula MJ (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1:147-153 (Pubitemid 33741968)
    • (2001) Nature Reviews Immunology , vol.1 , Issue.2 , pp. 147-153
    • Shlomchik, M.J.1    Craft, J.E.2    Mamula, M.J.3
  • 50
    • 78650354414 scopus 로고    scopus 로고
    • Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remission
    • Sloand EM, Olnes MJ, Shenoy A et al (2010a) Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remission. J Clin Oncol 28:5166-5173
    • (2010) J Clin Oncol , vol.28 , pp. 5166-5173
    • Sloand, E.M.1    Olnes, M.J.2    Shenoy, A.3
  • 51
    • 77949707207 scopus 로고    scopus 로고
    • Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab
    • Sloand EM, Olnes MJ, Weinstein B et al (2010b) Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab. Haematologica 95:382-387
    • (2010) Haematologica , vol.95 , pp. 382-387
    • Sloand, E.M.1    Olnes, M.J.2    Weinstein, B.3
  • 52
    • 0017738691 scopus 로고
    • Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions
    • Speck B, Gluckman E, Haak HL et al (1977) Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet 2:1145-1148 (Pubitemid 8231994)
    • (1977) Lancet , vol.2 , Issue.8049 , pp. 1145-1148
    • Speck, B.1    Gluckman, E.2    Haak, H.L.3    Van Rood, J.J.4
  • 53
    • 77950327120 scopus 로고    scopus 로고
    • Rituximab in autoimmune hematologic diseases: Not just a matter of B cells
    • Stasi R (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol 47:170-179
    • (2010) Semin Hematol , vol.47 , pp. 170-179
    • Stasi, R.1
  • 54
    • 0141792797 scopus 로고    scopus 로고
    • Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: Two case reports
    • Sugimori C, Kaito K, Nakao S (2003) Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: two case reports. Int J Hematol 77:391-394 (Pubitemid 37121838)
    • (2003) International Journal of Hematology , vol.77 , Issue.4 , pp. 391-394
    • Sugimori, C.1    Kaito, K.2    Nakao, S.3
  • 55
    • 79956034345 scopus 로고    scopus 로고
    • Aplastic anemia successfully treated with rituximab: The possible role of aplastic anemia-associated autoantibodies as a marker for response
    • Takamatsu H, Yagasaki H, Takahashi Y et al (2011) Aplastic anemia successfully treated with rituximab: the possible role of aplastic anemia-associated autoantibodies as a marker for response. Eur J Haematol 86:541-545
    • (2011) Eur J Haematol , vol.86 , pp. 541-545
    • Takamatsu, H.1    Yagasaki, H.2    Takahashi, Y.3
  • 56
    • 84920231225 scopus 로고
    • Aplastic anemia treated by marrow transplantation
    • Thomas ED, Storb R, Fefer A et al (1972) Aplastic anemia treated by marrow transplantation. Lancet 1:284-289
    • (1972) Lancet , vol.1 , pp. 284-289
    • Thomas, E.D.1    Storb, R.2    Fefer, A.3
  • 57
    • 78650382800 scopus 로고    scopus 로고
    • Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anemia
    • Vallejo C, Montesinos P, Rosell A et al (2009) Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood 114:a3194
    • (2009) Blood , vol.114
    • Vallejo, C.1    Montesinos, P.2    Rosell, A.3
  • 59
    • 0011437539 scopus 로고    scopus 로고
    • Acquired aplastic anemia
    • Schechter GP, Berliner N, Telen MJ (eds) The American Society of Hematology Education Program Book, Washington
    • Young NS (2000) Acquired aplastic anemia. In: Schechter GP, Berliner N, Telen MJ (eds) Hematology 2000. The American Society of Hematology Education Program Book, Washington, pp 18-38
    • (2000) Hematology 2000 , pp. 18-38
    • Young, N.S.1
  • 60
    • 0030912049 scopus 로고    scopus 로고
    • The pathophysiology of acquired aplastic anemia
    • DOI 10.1056/NEJM199705083361906
    • Young NS, Maciejewski JP (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372 (Pubitemid 27208621)
    • (1997) New England Journal of Medicine , vol.336 , Issue.19 , pp. 1365-1372
    • Young, N.S.1    Maciejewski, J.2
  • 61
    • 33745438684 scopus 로고    scopus 로고
    • Immunosuppressive therapy for acquired severe aplastic anemia (SAA): A prospective comparison of four different regimens
    • DOI 10.1016/j.exphem.2006.03.017, PII S0301472X06002384
    • Zheng Y, Liu Y, Chu Y et al (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol 34:826-831 (Pubitemid 43949184)
    • (2006) Experimental Hematology , vol.34 , Issue.7 , pp. 826-831
    • Zheng, Y.1    Liu, Y.2    Chu, Y.3
  • 62
    • 0022006029 scopus 로고
    • Circulating activated suppressor T lymphocytes in aplastic anemia
    • Zoumbos NC, Gascón P, Djeu JY et al (1985) Circulating activated suppressor T lymphocytes in Aplastic anemia. N Engl J Med 312:257-265 (Pubitemid 15199363)
    • (1985) New England Journal of Medicine , vol.312 , Issue.5 , pp. 257-265
    • Zoumbos, N.C.1    Gascon, P.2    Djeu, J.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.